Related Experiment Video
Updated: Aug 10, 2026
![PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F57243.jpg&w=3840&q=50)
PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke
Published on: June 14, 2018
[The importance of 111-indium marked leukocyte scintigraphy in inflammatory intracranial processes]
M Lange1, L Ziegler, C Hamburger
1Neurochirurgische Klinik der Ludwig-Maximilians-Universität München.
Insights
111-indium-labelled leukocyte scintigraphy is an 80% reliable method for diagnosing intracranial lesions but suffers from delays and supply issues. This limits its utility for neurosurgeons needing timely operational guidance.
Area of Science:
- Neurology
- Nuclear Medicine
- Diagnostic Imaging
Background:
- Inflammatory intracranial lesions require precise delimitation for effective neurosurgical intervention.
- 111-indium-labelled leukocyte scintigraphy is a diagnostic tool used in this context.
Observation:
- The method demonstrates reliable results in 80% of cases.
- However, 10% of cases yield false-positive or false-negative outcomes.
- Significant time loss occurs due to a 24-hour waiting period and supply chain challenges.
Findings:
- The diagnostic accuracy is limited by false results.
- Operational delays are inherent due to the lengthy procedure and logistical issues.
- The current method provides insufficient timely information for surgical decision-making.
Implications:
- There is a critical need to enhance the existing scintigraphy technique.
- Development of novel diagnostic approaches for inflammatory intracranial lesions is warranted.
- Improved diagnostic tools are essential for optimizing neurosurgical timing and patient outcomes.
Abstract:
111-indium-labelled leukocyte scintigraphy used for testing inflammatory intracranial lesion delimitation in differential diagnosis, shows reliable results in 80% of the cases, whereas 10% demonstrate false-positive as well as false-negative results. Loss of time is caused by the 24 h waiting period for measurement, and because of supply problems. Due to these drawbacks, this method is of only limited help to the neurosurgeon in quickly finding safe pointers for determining the time of operation if inflammatory intracranial lesions are suspected. Hence, this method requires to be improved upon, or a new one should be developed.
More Related Videos
08:17Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
Published on: February 23, 2024
07:59Integrated Protocol for Assessing Meningeal Lymphatics: Cisterna Magna Injection, Lymph Node Imaging, Meningeal Dissection, and Whole-Mount Staining
Published on: May 29, 2026